181 related articles for article (PubMed ID: 9045944)
1. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines.
Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R
Jpn J Cancer Res; 1996 Nov; 87(11):1153-9. PubMed ID: 9045944
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of undifferentiated-type gastric carcinoma.
Tamura G; Sato K; Akiyama S; Tsuchiya T; Endoh Y; Usuba O; Kimura W; Nishizuka S; Motoyama T
Lab Invest; 2001 Apr; 81(4):593-8. PubMed ID: 11304579
[TBL] [Abstract][Full Text] [Related]
3. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.
Tamura G; Yin J; Wang S; Fleisher AS; Zou T; Abraham JM; Kong D; Smolinski KN; Wilson KT; James SP; Silverberg SG; Nishizuka S; Terashima M; Motoyama T; Meltzer SJ
J Natl Cancer Inst; 2000 Apr; 92(7):569-73. PubMed ID: 10749913
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas.
Machado JC; Soares P; Carneiro F; Rocha A; Beck S; Blin N; Berx G; Sobrinho-Simões M
Lab Invest; 1999 Apr; 79(4):459-65. PubMed ID: 10211998
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.
Becker KF; Atkinson MJ; Reich U; Becker I; Nekarda H; Siewert JR; Höfler H
Cancer Res; 1994 Jul; 54(14):3845-52. PubMed ID: 8033105
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin gene mutations in human gastric carcinoma cell lines.
Oda T; Kanai Y; Oyama T; Yoshiura K; Shimoyama Y; Birchmeier W; Sugimura T; Hirohashi S
Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1858-62. PubMed ID: 8127895
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin gene mutations in signet ring cell carcinoma of the stomach.
Muta H; Noguchi M; Kanai Y; Ochiai A; Nawata H; Hirohashi S
Jpn J Cancer Res; 1996 Aug; 87(8):843-8. PubMed ID: 8797891
[TBL] [Abstract][Full Text] [Related]
8. The common 18-base pair deletion at codons 418-423 of the E-cadherin gene in differentiated-type adenocarcinomas and intramucosal precancerous lesions of the stomach with the features of gastric foveolar epithelium.
Endoh Y; Tamura G; Watanabe H; Ajioka Y; Motoyama T
J Pathol; 1999 Oct; 189(2):201-6. PubMed ID: 10547575
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma.
Fukudome Y; Yanagihara K; Takeichi M; Ito F; Shibamoto S
Int J Cancer; 2000 Nov; 88(4):579-83. PubMed ID: 11058874
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
[TBL] [Abstract][Full Text] [Related]
11. Rapid detection of mutated E-cadherin in peritoneal lavage specimens from patients with diffuse-type gastric carcinoma.
Schuhmacher C; Becker KF; Reich U; Schenk U; Mueller J; Siewert JR; Höfler H
Diagn Mol Pathol; 1999 Jun; 8(2):66-70. PubMed ID: 10475380
[TBL] [Abstract][Full Text] [Related]
12. Mutation, loss of heterozygosity, and recombination of the p53 gene in mouse forestomach tumors induced by 2-amino-3,4-dimethylimidazo[4,5-f]quinoline.
Ushijima T; Makino H; Okonogi H; Hosoya Y; Sugimura T; Nagao M
Mol Carcinog; 1995 Jan; 12(1):23-30. PubMed ID: 7818762
[TBL] [Abstract][Full Text] [Related]
13. Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas.
Sentani K; Oue N; Kondo H; Kuraoka K; Motoshita J; Ito R; Yokozaki H; Yasui W
Pathobiology; 2001; 69(6):315-20. PubMed ID: 12324708
[TBL] [Abstract][Full Text] [Related]
14. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas.
Becker KF; Atkinson MJ; Reich U; Huang HH; Nekarda H; Siewert JR; Höfler H
Hum Mol Genet; 1993 Jun; 2(6):803-4. PubMed ID: 8353498
[No Abstract] [Full Text] [Related]
15. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
Shi Y; Zou M; Farid NR; al-Sedairy ST
Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
[TBL] [Abstract][Full Text] [Related]
16. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
Handschuh G; Candidus S; Luber B; Reich U; Schott C; Oswald S; Becke H; Hutzler P; Birchmeier W; Höfler H; Becker KF
Oncogene; 1999 Jul; 18(30):4301-12. PubMed ID: 10439038
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the E-cadherin gene in human gynecologic cancers.
Risinger JI; Berchuck A; Kohler MF; Boyd J
Nat Genet; 1994 May; 7(1):98-102. PubMed ID: 8075649
[TBL] [Abstract][Full Text] [Related]
18. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
Kim HS; Hong EK; Park SY; Kim WH; Lee HS
Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
[TBL] [Abstract][Full Text] [Related]
19. Ile-Leu substitution (I415L) in germline E-cadherin gene (CDH1) in Japanese familial gastric cancer.
Wang Y; Song JP; Ikeda M; Shinmura K; Yokota J; Sugimura H
Jpn J Clin Oncol; 2003 Jan; 33(1):17-20. PubMed ID: 12604719
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations in thyroid tumor progression: association with p53 gene mutations.
Ito T; Seyama T; Mizuno T; Tsuyama N; Hayashi Y; Dohi K; Nakamura N; Akiyama M
Jpn J Cancer Res; 1993 May; 84(5):526-31. PubMed ID: 8100564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
